J B Chemicals & Pharmaceuticals Ltd Analyst Rating
based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts offering long term price targets for J B Chemicals & Pharmaceuticals Ltd. An average target of ₹2173.77
Source: S&P Global Market Intelligence
J B Chemicals & Pharmaceuticals Ltd Share analysis
J B Chemicals & Pharmaceuticals Ltd price forecast by 13 analysts
Upside of24.69%
High
₹2330
Target
₹2173.77
Low
₹1686
J B Chemicals & Pharmaceuticals Ltd target price ₹2173.77, a slight upside of 24.69% compared to current price of ₹1743.4. According to 13 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
J B Chemicals & Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2026:30.78%
Forecast
Actual
Including amortisation and stock based compensations
J B Chemicals & Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2026:55.80%
Forecast
Actual
Source: S&P Global Market Intelligence
J B Chemicals & Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹1,694.05₹1,753.9552 Week's Low
52 Week's High
₹1,371₹2,030
| Returns % | |
| 1 Month Return | -9.13 % |
| 3 Month Return | -7.55 % |
| 1 Year Return | + 21.16 % |
| Market Stats | |
| Previous Close | ₹1,702.05 |
| Open | ₹1,702.05 |
| Volume | 1.58L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹26,435.29Cr |
J B Chemicals & Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 44.17 |
| PEG Ratio | 3.5 |
| Market Cap | ₹26,435.29 Cr |
| P/B Ratio | 8.87 |
| EPS | 35.61 |
| Dividend Yield | 0.74 |
| Sector | Pharmaceuticals |
| ROE | 20.39 |
J B Chemicals & Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹26,435.29 Cr | 158.9% | 0.56 | ₹552 Cr | ₹3,484 Cr | |
| HOLD | ₹32,443.03 Cr | 133.7% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹18,006.48 Cr | 29.79% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹6,176.62 Cr | 3.81% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹15,982.20 Cr | 50.41% | 0.68 | ₹218 Cr | ₹1,296 Cr |
J B Chemicals & Pharmaceuticals Ltd Mutual Fund Holdings
About J B Chemicals & Pharmaceuticals Ltd
Share Price: ₹1743.40 per share as on 22 Nov, 2024 04:01 PM
Market Capitalisation: ₹26,435.29Cr as of today
Revenue: ₹1,000.62Cr as on September 2024 (Q3 24)
Net Profit: ₹174.57Cr as on September 2024 (Q3 24)
Listing date: 02 Feb, 1995
Chairperson Name: Ranjit Shahani.
| Organisation | J B Chemicals & Pharmaceuticals Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for J B Chemicals & Pharmaceuticals Ltd
J.B. Chemicals Maintains Buy Rating with Target Price - 11 Nov, 2024
Prabhudas Lilladher maintains a BUY rating on J.B. Chemicals & Pharmaceuticals with a target price of Rs 2,250. The company shows strong growth potential driven by geographical expansion, improved MR productivity, and new product launches, with an expected EPS CAGR of 24% over FY24-27E.
JB Chemicals Reports Strong Q2 2024 Financials - 07 Nov, 2024
JB Chemicals reported consolidated net sales of Rs 1,000.62 crore for September 2024, a 13.48% increase year-on-year. Net profit rose 15.92% to Rs 174.57 crore, with EBITDA up 11.65%. The EPS increased to Rs 11.24. Shares closed at Rs 1,880.70, reflecting a 33.04% gain over the past year.
KKR Considers Selling Stake in JB Chemicals - 06 Nov, 2024
KKR & Co is contemplating a sale of its controlling stake in JB Chemicals & Pharmaceuticals, potentially worth $750 million to $1 billion. The firm may reduce its stake from nearly 54% to about 25%. Shares of JB Pharma have surged 16% this year, reflecting strong investor interest. KKR's stake sale could occur in the coming weeks, with no final decisions made yet.
Positive Growth Outlook for J B Chemicals & Pharma - 16 Oct, 2024
Prabhudas Lilladher projects strong domestic growth for J B Chemicals & Pharma, driven by brand expansion and increased productivity. The firm anticipates an EBITDA CAGR of 18% and EPS CAGR of 23.5% from FY 2024 to 2027.
Insights on J B Chemicals & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, JBCHEPHARM stock has moved up by 3.8%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 12.17% to 13.63% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 851.86 Cr → 1.01K Cr (in ₹), with an average increase of 5.4% per quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 176.83 Cr → 174.57 Cr (in ₹), with an average decrease of 1.3% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 16.43% to 15.81% in Sep 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 53.77% to 53.74% in Sep 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 15.04% to 14.60% in Sep 2024 quarter
J B Chemicals & Pharmaceuticals Ltd Financials
Index Inclusions
J B Chemicals & Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.74% | ||
| Foreign Institutions | 13.63% | 12.03 | |
| Mutual Funds | 14.6% | ||
| Retail Investors | 15.81% | ||
| Others | 2.21% |
J B Chemicals & Pharmaceuticals Ltd Key Indicators
J B Chemicals & Pharmaceuticals Ltd Valuation
J B Chemicals & Pharmaceuticals Ltd in the last 5 years
Lowest (10.61x)
October 24, 2019
Today (44.17x)
November 22, 2024
Industry (54.77x)
November 22, 2024
Highest (62.92x)
February 7, 2024
J B Chemicals & Pharmaceuticals Ltd Earnings and Dividends
J B Chemicals & Pharmaceuticals Ltd Earnings Results
J B Chemicals & Pharmaceuticals Ltd’s net profit jumped 15.92% since last year same period to ₹174.57Cr in the Q2 2024-2025. On a quarterly growth basis, J B Chemicals & Pharmaceuticals Ltd has generated -1.28% fall in its net profits since last 3-months.
Read More about Earnings ResultsJ B Chemicals & Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, J B Chemicals & Pharmaceuticals Ltd has declared dividend of ₹6.75 - translating a dividend yield of 1.23%.
Read More about Dividends
J B Chemicals & Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
J B Chemicals & Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on J B Chemicals & Pharmaceuticals Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy J B Chemicals & Pharmaceuticals Ltd shares.
J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) share price today is ₹1743.4
J B Chemicals & Pharmaceuticals Ltd is listed on NSE
J B Chemicals & Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of J B Chemicals & Pharmaceuticals Ltd is ₹1753.95.
- Today’s lowest price of J B Chemicals & Pharmaceuticals Ltd is ₹1694.05.
PE Ratio of J B Chemicals & Pharmaceuticals Ltd is 44.17
PE ratio = J B Chemicals & Pharmaceuticals Ltd Market price per share / J B Chemicals & Pharmaceuticals Ltd Earnings per share
Today’s traded volume of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is 1.58L.
Today’s market capitalisation of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is ₹26435.29Cr.
| J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM | Price |
|---|---|
52 Week High | ₹2030 |
52 Week Low | ₹1371 |
J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) share price is ₹1743.4. It is down -14.12% from its 52 Week High price of ₹2030
J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) share price is ₹1743.4. It is up 27.16% from its 52 Week Low price of ₹1371
| J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM | Returns |
|---|---|
1 Day Returns | 41.35% |
1 Month Returns | -9.13% |
3 Month Returns | -7.55% |
1 Year Returns | 21.16% |